University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes : a post hoc analysis of the SABINA III study

dc.contributor.authorPrice, David
dc.contributor.authorBeekman, Maarten j. h. i.
dc.contributor.authorMattarucco, Walter javier
dc.contributor.authorBarriga-Acevedo, Rocio martina
dc.contributor.authorWang, Hao-Chien
dc.contributor.authorDiaz, Dina v.
dc.contributor.authorKhattab, Adel
dc.contributor.authorPacheco gallego, Manuel
dc.contributor.authorAl zaabi, Ashraf
dc.contributor.authorFarouk, Hisham
dc.contributor.authorAttar-Zadeh, Darush
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2024-11-04T14:21:01Z
dc.date.available2024-11-04T14:21:01Z
dc.date.issued2024-11-01
dc.descriptionAcknowledgements AstraZeneca funded all the SABINA studies and was involved in designing the study, developing the study protocol, conducting the study, and performing the analyses. AstraZeneca was given the opportunity to review the manuscript before submission and funded medical writing support. Writing and editorial support was provided by Praveen Kaul, PhD, of Cactus Life Sciences (part of Cactus Communications), Mumbai, India, in accordance with Good Publication Practice (GPP 2022) guidelines (https://www.acpjournals.org/doi/10.7326/M22-1460) and fully funded by AstraZeneca.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent1627990
dc.identifier298380750
dc.identifier2ffa01ed-e473-450a-9b7d-46d61054edcd
dc.identifier85208290306
dc.identifier.citationPrice, D, Beekman, M J H I, Mattarucco, W J, Barriga-Acevedo, R M, Wang, H-C, Diaz, D V, Khattab, A, Pacheco gallego, M, Al zaabi, A, Farouk, H & Attar-Zadeh, D 2024, 'Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes : a post hoc analysis of the SABINA III study', npj Primary Care Respiratory Medicine, vol. 34, no. 1, 34. https://doi.org/10.1038/s41533-024-00397-4en
dc.identifier.doi10.1038/s41533-024-00397-4
dc.identifier.iss1en
dc.identifier.issn2055-1010
dc.identifier.othercrossref: 10.1038/s41533-024-00397-4
dc.identifier.urihttps://hdl.handle.net/2164/24539
dc.identifier.vol34en
dc.language.isoeng
dc.relation.ispartofnpj Primary Care Respiratory Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectasthmaen
dc.subjecthealth policyen
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleOver-the-counter short-acting β2-agonist purchase and asthma-related health outcomes : a post hoc analysis of the SABINA III studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Price_etal_NPJPCRM_Over_The_Counter_VoR.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format

Collections